Tezepelumab for chronic sinusitis with severe asthma
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a medication called tezepelumab to see if it can improve symptoms for people with chronic sinusitis and nasal polyps who also have severe asthma. It may help reduce inflammation and improve breathing and nasal symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years of age or older.
- You have chronic sinusitis with nasal polyps (growths in the nose) and severe asthma.
- You have not had sinus surgery or nasal polyp removal before.
- You are not currently taking systemic corticosteroids (like prednisone) or other immunomodulating medications.
- You do not have aspirin/NSAID allergy, significant smoking history, or active infections.
- You are willing to use birth control (if applicable) and not planning sinus surgery in the next 7 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well tezepelumab works for people with chronic sinusitis and nasal polyps. It tracks symptoms and quality of life in real-world settings in Japan. If you have this condition and are considering tezepelumab, this study may help doctors understand its benefits.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
This study tests whether tezepelumab, a new injectable medicine, can help reduce nasal polyps and improve symptoms like nasal congestion, loss of smell, and sleep problems. You would receive the study drug while continuing your current nasal steroid spray, and your doctors would track how your symptoms change.
This study tests a medicine called tezepelumab (an injection) for people with severe asthma who also have a chronic cough. It may help reduce asthma attacks and improve cough symptoms.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
This study tests whether combining mepolizumab (a biologic injection) with a quick in-office removal of nasal polyps improves symptoms better than usual care. It is for adults with chronic sinusitis and nasal polyps who qualify for biologic therapy.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.